Anlon Healthcare IPO Details

Incorporated in 2013, Anlon Healthcare Limited is a specialty chemical manufacturing company focused on the production of high-purity pharmaceutical intermediates and active pharmaceutical ingredients (APIs). These products are critical components used in the formulation of medicines, nutraceuticals, personal care items, and veterinary products.

Core Capabilities

Anlon manufactures pharmaceutical intermediates and APIs in compliance with global pharmacopeia standards, including IP, BP, EP, JP, and USP. The company has also expanded into custom synthesis of complex chemicals, offering solutions that exceed purity requirements and meet stringent customer specifications.

The company's API portfolio includes products approved by major regulatory bodies such as:

• ANVISA (Brazil)
• NMPA (China)
• PMDA (Japan)

Notably, Anlon is among the few Indian manufacturers of Loxoprofen Sodium Dihydrate, a widely used anti-inflammatory API.

Product Portfolio (As of January 31, 2025)

Anlon’s portfolio spans 142 products across various stages of development:

• 65 Commercialized
• 28 At pilot stage
• 49 In laboratory testing

Breakdown by category:

• 22 Pharmaceutical Intermediates
• 18 Active Pharmaceutical Ingredients (APIs)
• 20 Nutraceutical APIs
• 3 Personal Care Intermediates
• 2 Veterinary APIs

The company has filed 21 Drug Master Files (DMFs) across global jurisdictions and is actively pursuing additional filings, including for Ketoprofen and Dexketoprofen Trometamol.

Manufacturing and Quality

With a strong focus on quality, safety, and environmental responsibility, Anlon ensures all products undergo rigorous testing, analysis, and process validation. Supported by four in-house laboratories, the company's quality systems are managed by a 34-member team—including 24 science graduates—dedicated to R&D, QC, and QA.

Workforce

As of January 31, 2025, Anlon employed:

• 105 full-time employees (excluding trainees)
• 8 contract workers

Key Products

• Pharma Intermediates: Examples include Cyanoethylbenzoic Acid, Ketonitrile, and Methyldesloratadine, used as starting materials or advanced intermediates in API manufacturing.
• Active Pharmaceutical Ingredients (APIs): Used in tablets, capsules, syrups, ointments, and other formulations across human and animal health, nutraceuticals, and personal care.

Global Reach

Anlon serves clients in over 15 countries, including Italy, Germany, Japan, and Brazil.

Competitive Strengths

• Diverse and scalable product portfolio
• Strong promoter backing and experienced management
• High entry barriers due to long customer approval cycles
• In-house capabilities for testing, quality control, and assurance
• Commitment to quality, environment, health, and safety standards